1.1.1.105 all-trans-retinol dehydrogenase (NAD+) prostate gland - 697796 1.1.1.14 L-iditol 2-dehydrogenase prostate gland ventral and dorsal 285881 1.1.1.141 15-hydroxyprostaglandin dehydrogenase (NAD+) prostate gland androgen-sensitive cancer cells LNCaP and hormone-independent PC3 cells, enzyme expression is induced by steroids 285939 1.1.1.141 15-hydroxyprostaglandin dehydrogenase (NAD+) prostate gland very low expression level 669380 1.1.1.145 3beta-hydroxy-DELTA5-steroid dehydrogenase prostate gland - 763756 1.1.1.146 11beta-hydroxysteroid dehydrogenase prostate gland - 668432, 699847, 761757 1.1.1.146 11beta-hydroxysteroid dehydrogenase prostate gland presence of 11beta-hydroxysteroid dehydrogenase mRNA transcripts and protein in all tissues of the reproductive tract examined, but cortison-cortisol interconversion is undetectable in the corpus and cauda epididymides, vas deferens, vesicular and prostate glands 695090 1.1.1.149 20alpha-hydroxysteroid dehydrogenase prostate gland 20alpha-HSD mRNA lower expressed 285997 1.1.1.188 prostaglandin-F synthase prostate gland low expression level 760437 1.1.1.209 3(or 17)alpha-hydroxysteroid dehydrogenase prostate gland - 389547 1.1.1.213 3alpha-hydroxysteroid 3-dehydrogenase (Re-specific) prostate gland - 347987, 668392, 676812 1.1.1.213 3alpha-hydroxysteroid 3-dehydrogenase (Re-specific) prostate gland epithelial cells, but not the stromal cells or endothelial cells 688137 1.1.1.213 3alpha-hydroxysteroid 3-dehydrogenase (Re-specific) prostate gland in primary prostate stromal cells, co-localization with RODH like 3alpha/17beta-HSD, EC 1.1.1.239 676002 1.1.1.22 UDP-glucose 6-dehydrogenase prostate gland increased UGDH expression in cancerous acini and decreased expression in normal-appearing acini of the same prostate relative to acini of non-cancerous prostates 698331 1.1.1.239 3alpha(17beta)-hydroxysteroid dehydrogenase (NAD+) prostate gland - 287211, 287212 1.1.1.239 3alpha(17beta)-hydroxysteroid dehydrogenase (NAD+) prostate gland androgen target tissues 673341 1.1.1.300 NADP-retinol dehydrogenase prostate gland - 654687, 656064, 762061 1.1.1.315 11-cis-retinol dehydrogenase prostate gland 21% mRNA expression of Rdh5 compared to liver 690797 1.1.1.357 3alpha-hydroxysteroid 3-dehydrogenase prostate gland - 724711 1.1.1.50 3alpha-hydroxysteroid 3-dehydrogenase (Si-specific) prostate gland - 389529, 389531, 389540, 389547, 389551 1.1.1.50 3alpha-hydroxysteroid 3-dehydrogenase (Si-specific) prostate gland epithelial cells, but not the stromal cells or endothelial cells 688137 1.1.1.51 3(or 17)beta-hydroxysteroid dehydrogenase prostate gland isozyme 17beta-HSD5 675983 1.1.1.62 17beta-estradiol 17-dehydrogenase prostate gland - 654934, 670033, 686263, 762074 1.1.1.62 17beta-estradiol 17-dehydrogenase prostate gland epithelial cells of the acini and stromal cells 675190 1.1.1.62 17beta-estradiol 17-dehydrogenase prostate gland moderate expression 685803 1.1.1.71 alcohol dehydrogenase [NAD(P)+] prostate gland - 655563 1.1.1.95 phosphoglycerate dehydrogenase prostate gland - 287528 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (NAD+) prostate gland - 285953, 699847 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (NAD+) prostate gland presence of 11beta-hydroxysteroid dehydrogenase mRNA transcripts and protein in all tissues of the reproductive tract examined, but cortison-cortisol interconversion is undetectable in the corpus and cauda epididymides, vas deferens, vesicular and prostate glands 695090 1.1.2.4 D-lactate dehydrogenase (cytochrome) prostate gland - 740447 1.11.1.12 phospholipid-hydroperoxide glutathione peroxidase prostate gland - 671327 1.11.1.9 glutathione peroxidase prostate gland - 685952, 701039 1.11.1.9 glutathione peroxidase prostate gland expression is observed in the membranes of vacuoles contained in prostate secretions as well as in the endothelium of arterioles and venules 690120 1.13.11.33 arachidonate 15-lipoxygenase prostate gland - 659222, 674995, 676263 1.13.11.5 homogentisate 1,2-dioxygenase prostate gland - 439387 1.13.11.63 beta-carotene 15,15'-dioxygenase prostate gland - 713952 1.13.11.63 beta-carotene 15,15'-dioxygenase prostate gland low levels of BCO mRNA 438228 1.13.11.71 carotenoid-9',10'-cleaving dioxygenase prostate gland prostate connective tissue 720152 1.14.11.33 DNA oxidative demethylase prostate gland high ABH3 mRNA levels 723671 1.14.11.65 [histone H3]-dimethyl-L-lysine9 demethylase prostate gland - 754938 1.14.11.65 [histone H3]-dimethyl-L-lysine9 demethylase prostate gland lysine-specific demethylase 1 colocalizes with androgen receptor 670377 1.14.13.8 flavin-containing monooxygenase prostate gland - 686276 1.14.14.29 25/26-hydroxycholesterol 7alpha-hydroxylase prostate gland CYP7B1 is overexpressed in high-grade prostatic intraepithelial neoplasia and in prostate cancer 689846 1.14.14.79 docosahexaenoic acid omega-hydroxylase prostate gland - 728344 1.14.14.94 leukotriene-B4 20-monooxygenase prostate gland mRNA for CYP4F8 detected 660409 1.14.15.18 calcidiol 1-monooxygenase prostate gland - 675686 1.14.99.1 prostaglandin-endoperoxide synthase prostate gland - 438404 1.14.99.1 prostaglandin-endoperoxide synthase prostate gland anterior prostate 672503 1.2.1.3 aldehyde dehydrogenase (NAD+) prostate gland - 655948, 686531 1.2.1.31 L-aminoadipate-semialdehyde dehydrogenase prostate gland - 288202 1.2.1.31 L-aminoadipate-semialdehyde dehydrogenase prostate gland mRNA expression 675897 1.2.1.5 aldehyde dehydrogenase [NAD(P)+] prostate gland - 686531 1.21.99.4 thyroxine 5'-deiodinase prostate gland - 701040 1.3.1.1 dihydropyrimidine dehydrogenase (NAD+) prostate gland - 685782 1.3.1.124 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] prostate gland - 759825 1.3.1.22 3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) prostate gland - 390655, 390656, 390657, 396200, 396204, 396217, 396219, 396220, 656681, 675475, 675683, 686575, 687218, 688684, 688718, 688719, 689849 1.3.1.22 3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) prostate gland hyperplastic 396202, 396208, 396211 1.3.1.22 3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) prostate gland studies in DU 145 cells, a human cell-line of low androgen sensitivity derived from a cerebral metastasis of an ephithelial prostate cancer 396218, 396223 1.3.1.22 3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) prostate gland type-2 5alpha-reductase is only found in prostate and other genital tissues, enhancement of type-1 5alpha-reductase is enhanced in prostate cancer 684816 1.3.1.22 3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) prostate gland ventral 396192, 396193, 396209 1.3.1.22 3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) prostate gland ventral prostate, activity of both isoform I and II is increased after treatment with oxytocin 655351 1.3.1.70 DELTA14-sterol reductase prostate gland TM7SF2 672378 1.3.99.5 3-oxo-5alpha-steroid 4-dehydrogenase (acceptor) prostate gland - -, 657354, 668281, 670738, 712201 1.3.99.5 3-oxo-5alpha-steroid 4-dehydrogenase (acceptor) prostate gland prostate cancer cell 670032 1.3.99.5 3-oxo-5alpha-steroid 4-dehydrogenase (acceptor) prostate gland prostate cancer cell lines 669566 1.3.99.5 3-oxo-5alpha-steroid 4-dehydrogenase (acceptor) prostate gland type 2 5alpha-reductase mRNA is predominantly expressed in the prostate gland 662726 1.3.99.5 3-oxo-5alpha-steroid 4-dehydrogenase (acceptor) prostate gland ventral prostate 669811 1.3.99.5 3-oxo-5alpha-steroid 4-dehydrogenase (acceptor) prostate gland very low activity 391397 1.4.3.21 primary-amine oxidase prostate gland - 703130 1.4.3.4 monoamine oxidase prostate gland is highly expressed in basal cells of the normal prostatic epithelium and in poorly differentiated, aggressive prostate cancer 702900 1.4.3.5 pyridoxal 5'-phosphate synthase prostate gland 16.5% of the activity in liver 655483 1.5.1.6 formyltetrahydrofolate dehydrogenase prostate gland moderate FDH mRNA level 392350 1.5.3.13 N1-acetylpolyamine oxidase prostate gland - 703028 1.6.3.1 NAD(P)H oxidase (H2O2-forming) prostate gland - 711688 1.8.1.9 thioredoxin-disulfide reductase prostate gland - 658795, 701340 1.8.1.9 thioredoxin-disulfide reductase prostate gland isoform TR1 394945 1.8.3.2 thiol oxidase prostate gland - 668207 1.8.3.2 thiol oxidase prostate gland small amounts 393063 1.8.4.2 protein-disulfide reductase (glutathione) prostate gland DU145 carcinoma 394854 2.1.1.137 arsenite methyltransferase prostate gland moderate expression 758507 2.1.1.137 arsenite methyltransferase prostate gland weak expression 758507 2.1.1.20 glycine N-methyltransferase prostate gland - 704524 2.1.1.72 site-specific DNA-methyltransferase (adenine-specific) prostate gland - 719373 2.3.1.5 arylamine N-acetyltransferase prostate gland - 675601 2.3.1.5 arylamine N-acetyltransferase prostate gland NAT1 is strongly localized to androgen-positive epithelium in human prostate 672920 2.3.1.51 1-acylglycerol-3-phosphate O-acyltransferase prostate gland - 705206 2.3.1.56 aromatic-hydroxylamine O-acetyltransferase prostate gland - 487253 2.3.1.68 glutamine N-acyltransferase prostate gland - 758269 2.3.1.B43 protein-lysine desuccinylase (NAD+) prostate gland - 755970 2.3.2.13 protein-glutamine gamma-glutamyltransferase prostate gland TG4 expression is restricted to the prostate gland 759166 2.3.2.2 gamma-glutamyltransferase prostate gland - 487898, 487932 2.3.2.2 gamma-glutamyltransferase prostate gland secretion into seminal plasma 487940 2.3.2.8 arginyltransferase prostate gland - 488023 2.3.3.10 hydroxymethylglutaryl-CoA synthase prostate gland - 720426 2.4.1.150 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase prostate gland IGnT is highly expressed in adult prostata 638567 2.4.1.17 glucuronosyltransferase prostate gland - 488786, 488790, 693011 2.4.1.214 glycoprotein 3-alpha-L-fucosyltransferase prostate gland - 349718 2.4.1.313 protein O-mannose beta-1,3-N-acetylgalactosaminyltransferase prostate gland - 725358 2.4.1.41 polypeptide N-acetylgalactosaminyltransferase prostate gland - 719570 2.4.1.41 polypeptide N-acetylgalactosaminyltransferase prostate gland Northern blot analysis of human tissues 659136 2.4.1.69 type 1 galactoside alpha-(1,2)-fucosyltransferase prostate gland prostatic epithelial cells derived from patients with benign prostatic hyperplasia and from patients with prostatic cancer 489361 2.4.2.10 orotate phosphoribosyltransferase prostate gland normal tissue, hormone-sensitive prostate cancer (HSPC) or hormonerefractory prostate cancer (HRPC) tissue 706025 2.4.2.28 S-methyl-5'-thioadenosine phosphorylase prostate gland - 637526, 637540, 736923 2.4.2.9 uracil phosphoribosyltransferase prostate gland - 675195 2.4.2.9 uracil phosphoribosyltransferase prostate gland low level of expression 675195 2.5.1.16 spermidine synthase prostate gland - -, 489861, 489870, 489872, 489876, 639699, 639700, 639702, 639709, 661300, 661303 2.5.1.16 spermidine synthase prostate gland ventral -, 639701, 639705 2.5.1.18 glutathione transferase prostate gland - 674060 2.5.1.22 spermine synthase prostate gland - -, 489861, 489867, 489870, 489872 2.5.1.6 methionine adenosyltransferase prostate gland mainly MAT2beta variant 1 686926 2.7.1.1 hexokinase prostate gland intermediate expression in basal cells. Low to intermediate expression in stromal cells. Low expression in gland epithelium 759579 2.7.1.147 ADP-specific glucose/glucosamine kinase prostate gland - 723169 2.7.1.154 phosphatidylinositol-4-phosphate 3-kinase prostate gland isozyme PI3K-C2alpha inbasal epithelium and fibromuscular stroma, no isozyme PI3K-C2beta and isozyme p85 645046 2.7.1.31 glycerate 3-kinase prostate gland - 673281 2.7.10.2 non-specific protein-tyrosine kinase prostate gland activity is significantly lower in prostate cancer tissue after androgen withdrawal and is also low in prostate cancer cell lines 491949 2.7.11.1 non-specific serine/threonine protein kinase prostate gland overexpression in malignant prostate glandular cells 673433 2.7.11.12 cGMP-dependent protein kinase prostate gland transition zone, distribution of cGKI 673462 2.7.11.17 Ca2+/calmodulin-dependent protein kinase prostate gland low expression level of CaM-K1delta 664928 2.7.11.19 phosphorylase kinase prostate gland - 676038 2.7.11.24 mitogen-activated protein kinase prostate gland - 665029, 706581 2.7.4.6 nucleoside-diphosphate kinase prostate gland high expression 761777 2.8.2.2 alcohol sulfotransferase prostate gland - 738296, 761169, 761662, 761881 2.8.2.2 alcohol sulfotransferase prostate gland prostate epithelial cells, prostate benign prostatic hyperplasia, prostate adenocarcinoma and LNCaP prostate adenocarcinoma cells 675680 2.8.2.20 protein-tyrosine sulfotransferase prostate gland - 674372, 705836 3.1.1.4 phospholipase A2 prostate gland - 133865 3.1.21.7 deoxyribonuclease V prostate gland - 730709 3.1.3.1 alkaline phosphatase prostate gland - 94574 3.1.3.16 protein-serine/threonine phosphatase prostate gland low enzyme expression level 666301 3.1.3.2 acid phosphatase prostate gland - 134698, 134741, 134750, 134758, 134759, 134788, 664939 3.1.3.2 acid phosphatase prostate gland age- and sex-dependent enzyme expression level, overview 664547 3.1.3.2 acid phosphatase prostate gland carcinoma prostate, benign prostate hypertrophy, normal prostate 134726 3.1.3.2 acid phosphatase prostate gland isoenzyme PAP-I and PAP-II 134726 3.1.3.2 acid phosphatase prostate gland low in fetal tissue, during development activity gradually increases 134690 3.1.3.4 phosphatidate phosphatase prostate gland - 665805 3.1.3.4 phosphatidate phosphatase prostate gland isoenzyme PAP2a 134884 3.1.3.43 [pyruvate dehydrogenase (acetyl-transferring)]-phosphatase prostate gland - 751678 3.1.3.46 fructose-2,6-bisphosphate 2-phosphatase prostate gland - 730530 3.1.3.66 phosphatidylinositol-3,4-bisphosphate 4-phosphatase prostate gland - 714648, 751762, 752313 3.1.3.9 glucose-6-phosphatase prostate gland - 134945 3.1.4.17 3',5'-cyclic-nucleotide phosphodiesterase prostate gland epithelial, endothelial and smooth muscle cells 669701 3.1.4.17 3',5'-cyclic-nucleotide phosphodiesterase prostate gland PDE11 668987 3.1.4.17 3',5'-cyclic-nucleotide phosphodiesterase prostate gland PDE11A2 668989 3.1.4.17 3',5'-cyclic-nucleotide phosphodiesterase prostate gland PDE11A4 668989 3.1.4.17 3',5'-cyclic-nucleotide phosphodiesterase prostate gland PDE11A4, strong antibody staining in the glandular epithelium 668988 3.1.4.35 3',5'-cyclic-GMP phosphodiesterase prostate gland - 711934 3.1.6.12 N-acetylgalactosamine-4-sulfatase prostate gland - 751772, 752087 3.1.6.4 N-acetylgalactosamine-6-sulfatase prostate gland - 751772 3.13.2.1 adenosylhomocysteinase prostate gland - -, 137149 3.3.2.9 microsomal epoxide hydrolase prostate gland - 208880, 208881, 699759 3.4.11.2 membrane alanyl aminopeptidase prostate gland - 701038 3.4.13.18 cytosol nonspecific dipeptidase prostate gland - 36115 3.4.13.9 Xaa-Pro dipeptidase prostate gland - 36115 3.4.14.5 dipeptidyl-peptidase IV prostate gland - 697519 3.4.15.1 peptidyl-dipeptidase A prostate gland - 755108, 81211 3.4.17.21 Glutamate carboxypeptidase II prostate gland - 137211, 137212, 137213, 669595, 670794, 753584 3.4.17.21 Glutamate carboxypeptidase II prostate gland epithelial cells 668154 3.4.17.21 Glutamate carboxypeptidase II prostate gland highly expressed, might be associated with prostate cancer progression 755286 3.4.17.21 Glutamate carboxypeptidase II prostate gland prostate form of the enzyme is termed prostate-specific membrane antigen 667114, 670817 3.4.17.21 Glutamate carboxypeptidase II prostate gland prostate-specific membrane antigen, PSMA 670363 3.4.17.21 Glutamate carboxypeptidase II prostate gland prostrate carcinoma cell line LNCaP 137218, 137219, 137226, 137230 3.4.17.21 Glutamate carboxypeptidase II prostate gland quantitative expression analysis 670740 3.4.17.22 metallocarboxypeptidase D prostate gland - 755287 3.4.17.3 lysine carboxypeptidase prostate gland benign hypertrophy 36402 3.4.21.109 matriptase prostate gland - 683893 3.4.21.117 stratum corneum chymotryptic enzyme prostate gland - 718165, 752620 3.4.21.122 transmembrane protease serine 2 prostate gland - 752699, 753731, 753735 3.4.21.122 transmembrane protease serine 2 prostate gland and kidney, main expression sites. Expression is localized in the luminal epithelial cells 754468 3.4.21.122 transmembrane protease serine 2 prostate gland highest expression level, localized in luminal epithelial cells 754468 3.4.21.122 transmembrane protease serine 2 prostate gland highest expression of TMPRSS2 at the apical side of prostate and prostate cancer secretory epithelia and within the lumen of the glands 764399 3.4.21.122 transmembrane protease serine 2 prostate gland TMPRSS2 protein is abundantly expressed in the prostate. Protein is specifically localized to the secretory epithelium, with enhanced expression in the plasma membrane orientated towards the ductal lumen 753135 3.4.21.35 tissue kallikrein prostate gland - 647332, 647503, 647523, 647536, 678468, 696531, 698327 3.4.21.35 tissue kallikrein prostate gland low content 647332 3.4.21.35 tissue kallikrein prostate gland prostate-specific 647531 3.4.21.42 complement subcomponent C1s prostate gland - 753047 3.4.21.73 u-Plasminogen activator prostate gland - 29578 3.4.21.77 semenogelase prostate gland - 680680 3.4.21.77 semenogelase prostate gland concentration of enzyme in nonprostatic tissue represents less than 1% of the amount in normal prostate 665230 3.4.21.B10 neurosin prostate gland splice variant 3 is preferentially expressed in spinal cord, mammary, and salivary glands and to lesser extent in protstate 663841 3.4.21.B12 prostase prostate gland - 680680, 681390, 717674, 718348 3.4.21.B12 prostase prostate gland healthy prostate, highest amount of enzyme 668285 3.4.21.B12 prostase prostate gland predominant expression in basal cells of prostate gland 668144 3.4.21.B12 prostase prostate gland very low enzyme levels in healthy tissue 731893 3.4.21.B39 stratum corneum tryptic enzyme prostate gland - 669444 3.4.21.B39 stratum corneum tryptic enzyme prostate gland low expression 670977 3.4.21.B42 hippostasin prostate gland - 718165 3.4.21.B42 hippostasin prostate gland isozyme 2 679747 3.4.21.B43 kallikrein 12 prostate gland - 682623 3.4.21.B45 kallikrein 14 prostate gland - 667860 3.4.21.B6 prostasin prostate gland - 677453 3.4.21.B6 prostasin prostate gland enzyme levels 20fold higher than in other tissues 673905 3.4.21.B6 prostasin prostate gland epithelial cell and duct 651845 3.4.22.38 cathepsin K prostate gland low activity 30368 3.4.22.41 cathepsin F prostate gland - 137259 3.4.22.42 cathepsin O prostate gland - 137267 3.4.23.3 gastricsin prostate gland - 36848, 668809, 718005 3.4.23.45 memapsin 1 prostate gland - 668810 3.4.24.11 neprilysin prostate gland high activity in glandular epithelium, weak activity in stroma 670735 3.4.24.24 gelatinase A prostate gland - 752865 3.4.24.35 gelatinase B prostate gland - 670741 3.4.24.56 insulysin prostate gland activity and amount of enzyme decrease in the cytosolic fraction with castration and increase with testpsterone treatment 668492 3.4.24.7 interstitial collagenase prostate gland enzyme expression is significantly stronger in the epithelium than in the stroma 667214 3.4.24.71 endothelin-converting enzyme 1 prostate gland primary cells derived from benign tissue from radical prostatectomies, expression and localization of the ECE-1 isozymes, overview 683435 3.4.24.B11 ADAMTS1 endopeptidase prostate gland prostate stromal cell 670737 3.4.24.B7 matrix metalloproteinase-26 prostate gland - 754226 3.4.24.B9 ADAM9 endopeptidase prostate gland elevated level of enzyme in malignant compared to benign tissue. Increase in enzyme protein and mRNA upon exposure of prostate cells to stress conditions. Inhibition of stress-induction of enzyme by actinomycin D and cycloheximide 668164 3.5.1.23 ceramidase prostate gland - 719608 3.5.1.60 N-(long-chain-acyl)ethanolamine deacylase prostate gland - 752811 3.5.4.3 guanine deaminase prostate gland - 209590 3.6.1.1 inorganic diphosphatase prostate gland - 686943 4.1.1.17 ornithine decarboxylase prostate gland - 665902 4.1.1.17 ornithine decarboxylase prostate gland ornithine decarboxylase protein is expressed in the epithelium of the ventral, dorsolateral and anterior lobes of the adult mouse prostate -, 749065 4.1.1.28 aromatic-L-amino-acid decarboxylase prostate gland total RNA is isolated from tissue specimens from benign prostate hyperplasia and prostate cancer patients 691846 4.1.1.29 sulfinoalanine decarboxylase prostate gland CSD is expressed in the epithelial cells of the intermediate segments of prostate gland 703099 4.1.1.50 adenosylmethionine decarboxylase prostate gland - 4667, 4668, 4669, 4682, 714391, 714392 4.1.1.50 adenosylmethionine decarboxylase prostate gland ventral 4679 4.2.1.1 carbonic anhydrase prostate gland - 33547 4.2.1.1 carbonic anhydrase prostate gland contains carbonic anhydrase I, II and III 33541 4.2.1.11 phosphopyruvate hydratase prostate gland - 33611 4.2.1.3 aconitate hydratase prostate gland - 33810 4.2.1.3 aconitate hydratase prostate gland epithelium 33810 4.2.1.3 aconitate hydratase prostate gland mitochondrial isozyme plays the key role in the bioenergetic theory of malignant transformation of the prostate 696168 4.2.1.47 GDP-mannose 4,6-dehydratase prostate gland - 5732 4.3.2.9 gamma-glutamylcyclotransferase prostate gland - 687744 5.1.3.17 heparosan-N-sulfate-glucuronate 5-epimerase prostate gland - 749412 5.1.99.4 alpha-methylacyl-CoA racemase prostate gland - 663582, 665035, 666797, 677438, 680093, 682625, 701605 5.1.99.4 alpha-methylacyl-CoA racemase prostate gland from healthy persons, and after cystoprostatectomy and radical prostatectomy, overview, enzyme activity in prostate is increased from normal looking epithelial cells and atrophy, to prostatic intraepithelial neoplasia, away from and adjacent to prostate carcinoma, the expression in prostate carcinoma is slightly lower in cystoprostatectomy compared to radical prostatectomy specimen, immunohistochemic detection, overview 677439 5.1.99.4 alpha-methylacyl-CoA racemase prostate gland from patients with prostate carcinoma, atypia and benign hyperplasia 703387 5.1.99.4 alpha-methylacyl-CoA racemase prostate gland high grade prostatic intraepithelial neoplasia 666796 5.1.99.4 alpha-methylacyl-CoA racemase prostate gland low expression level 680073 5.3.1.21 corticosteroid side-chain-isomerase prostate gland - 2655 5.6.1.5 proteasome ATPase prostate gland - 697635 6.1.1.12 aspartate-tRNA ligase prostate gland - 744436 7.2.2.10 P-type Ca2+ transporter prostate gland - 669343, 718751 7.2.2.19 H+/K+-exchanging ATPase prostate gland anterior 671221 7.2.2.19 H+/K+-exchanging ATPase prostate gland healthy, benign and malignant prostate tissue, ATP12A expression levels, overview 719250 7.6.2.3 ABC-type glutathione-S-conjugate transporter prostate gland - 747222